Myocarditis in Clinical Practice

Mayo Clinic Proceedings

Volumn 91, Issue 9, 2016, Pages 1256-1266

  Sinagra, Gianfranco ^a   Anzini, Marco ^a   Pereira, Naveen L ^b   Bussani, Rossana ^a   Finocchiaro, Gherardo ^c   Bartunek, Jozef ^d   Merlo, Marco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b MAYO CLINIC   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EVIDENCE BASED PRACTICE; HEART MUSCLE BIOPSY; HOLTER MONITORING; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE PROCEDURE; MEDICAL HISTORY; MYOCARDITIS; NON INVASIVE PROCEDURE; PROGNOSIS; REVIEW; BIOPSY; EVIDENCE BASED MEDICINE; PATHOPHYSIOLOGY; PROCEDURES;

BIOPSY; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDITIS;

EID: 84990990163     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2016.05.013     Document Type: Review

References (50)

1. 1 Aretz, H.T., Billingham, M.E., Edwards, W.D., et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:1 (1987), 3–14.
2. 2 Richardson, P., McKenna, W., Bristow, M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:5 (1996), 841–842.
3. 3 Caforio, A.L.P., Pankuweit, S., Arbustini, E., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:33 (2013), 2636–2648.
4. 4 Anzini, M., Merlo, M., Sabbadini, G., et al. Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation 128:22 (2013), 2384–2394.
5. 5 Dennert, R., Crijns, H.J., Heymans, S., Acute viral myocarditis. Eur Heart J 29:17 (2008), 2073–2082.
6. 6 Kytö, V., Sipilä, J., Rautava, P., The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood. Heart 99:22 (2013), 1681–1684.
7. 7 Felker, G.M., Thompson, R.E., Hare, J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:15 (2000), 1077–1084.
8. 8 Hufnagel, G., Pankuweit, S., Richter, A., Schönian, U., Maisch, B., The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID): first epidemiological results. Herz 25:3 (2000), 279–285.
9. 9 Carniel, E., Sinagra, G., Bussani, R., et al. Fatal myocarditis: morphologic and clinical features. Ital Heart J 5:9 (2004), 702–706.
10. 10 Caforio, A.L.P., Calabrese, F., Angelini, A., et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:11 (2007), 1326–1333.
11. 11 Francone, M., Chimenti, C., Galea, N., et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging 7:3 (2014), 254–263.
12. 12 Buiatti, A., Merlo, M., Pinamonti, B., De Biasio, M., Bussani, R., Sinagra, G., Clinical presentation and long-term follow-up of perimyocarditis. J Cardiovasc Med (Hagerstown) 14:3 (2013), 235–241.
13. 13 Imazio, M., Brucato, A., Barbieri, A., et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation 128:1 (2013), 42–49.
14. 14 Šramko, M., Kubánek, M., Tintěra, J., et al. Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy. Am J Cardiol 111:2 (2013), 258–264.
15. 15 Mahfoud, F., Gärtner, B., Kindermann, M., et al. Virus serology in patients with suspected myocarditis: utility or futility?. Eur Heart J 32:7 (2011), 897–903.
16. 16 Pinamonti, B., Alberti, E., Cigalotto, A., et al. Echocardiographic findings in myocarditis. Am J Cardiol 62:4 (1988), 285–291.
17. 17 Felker, G.M., Boehmer, J.P., Hruban, R.H., et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:1 (2000), 227–232.
18. 18 Lurz, P., Eitel, I., Adam, J., et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 5:5 (2012), 513–524.
19. 19 Lurz, P., Eitel, I., Klieme, B., et al. The potential additional diagnostic value of assessing for pericardial effusion on cardiac magnetic resonance imaging in patients with suspected myocarditis. Eur Heart J Cardiovasc Imaging 15:6 (2014), 643–650.
20. 20 Gallagher, S., Jones, D.A., Anand, V., Mohiddin, S., Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms. Heart 98:13 (2012), 974–981.
21. 21 Gutberlet, M., Spors, B., Thoma, T., et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 246:2 (2008), 401–409.
22. 22 Bohnen, S., Radunski, U.K., Lund, G.K., et al. Performance of T1 and T2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ Cardiovasc Imaging, 8(6), 2015, e003073.
23. 23 Cooper, L.T., Baughman, K.L., Feldman, A.M., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology; endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 28:24 (2007), 3076–3093.
24. 24 Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128:16 (2013), e240–e327.
25. 25 Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:1 (2001), 39–45.
26. 26 Frustaci, A., Russo, M.A., Chimenti, C., Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:16 (2009), 1995–2002.
27. 27 Yilmaz, A., Kindermann, I., Kindermann, M., et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 122:9 (2010), 900–909.
28. 28 Bennett, M.K., Gilotra, N.A., Harrington, C., et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009. Circ Heart Fail 6:4 (2013), 676–684.
29. 29 Chimenti, C., Frustaci, A., Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation 128:14 (2013), 1531–1541.
30. 30 Baughman, K.L., Diagnosis of myocarditis: death of Dallas criteria. Circulation 113:4 (2006), 593–595.
31. 31 Escher, F., Lassner, D., Kühl, U., et al. Analysis of endomyocardial biopsies in suspected myocarditis—diagnostic value of left versus right ventricular biopsy. Int J Cardiol 177:1 (2014), 76–78.
32. 32 Leone, O., Veinot, J.P., Angelini, A., et al. 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21:4 (2012), 245–274.
33. 33 Kindermann, I., Kindermann, M., Kandolf, R., et al. Predictors of outcome in patients with suspected myocarditis. [published correction appears in Circulation. 2008;118(12):e493] Circulation 118:6 (2008), 639–648.
34. 34 McCarthy, R.E. III, Boehmer, J.P., Hruban, R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:10 (2000), 690–695.
35. 35 Magnani, J.W., Danik, H.J.S., Dec, G.W. Jr., DiSalvo, T.G., Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 151:2 (2006), 463–470.
36. 36 Ukena, C., Mahfoud, F., Kindermann, I., Kandolf, R., Kindermann, M., Böhm, M., Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail 13:4 (2011), 398–405.
37. 37 Grün, S., Schumm, J., Greulich, S., et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 59:18 (2012), 1604–1615.
38. 38 Quigley, P.J., Richardson, P.J., Meany, B.T., et al. Long-term follow-up of acute myocarditis: correlation of ventricular function and outcome. Eur Heart J 8:suppl J (1987), 39–42.
39. 39 Masci, P.G., Schuurman, R., Andrea, B., et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6:5 (2013), 790–799.
40. 40 Anzini, M., Merlo, M., Artico, J., Sinagra, G., Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias. [letter] Int J Cardiol 212 (2016), 169–170.
41. 41 Mason, J.W., O'Connell, J.B., Herskowitz, A., et al. Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:5 (1995), 269–275.
42. 42 Kühl, U., Lassner, D., von Schlippenbach, J., Poller, W., Schultheiss, H.-P., Interferon-beta improves survival in enterovirus-associated cardiomyopathy. [letter] J Am Coll Cardiol 60:14 (2012), 1295–1296.
43. 43 McNamara, D.M., Holubkov, R., Starling, R.C., et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103:18 (2001), 2254–2259.
44. 44 Dennert, R., Velthuis, S., Schalla, S., et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 15:2 (2010), 193–201.
45. 45 Kühl, U., Pauschinger, M., Bock, T., et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108:8 (2003), 945–950.
46. 46 Kühl, U., Pauschinger, M., Noutsias, M., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:7 (2005), 887–893.
47. 47 Kubánek, M., Šramko, M., Berenová, D., et al. Detection of Borrelia burgdorferi sensu lato in endomyocardial biopsy specimens in individuals with recent-onset dilated cardiomyopathy. Eur J Heart Fail 14:6 (2012), 588–596.
48. 48 Dennert, R., van Paassen, P., Wolffs, P., et al. Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseases. Clin Vaccine Immunol 19:8 (2012), 1182–1187.
49. 49 Moimas, S., Zacchigna, S., Merlo, M., et al. Idiopathic dilated cardiomyopathy and persistent viral infection: lack of association in a controlled study using a quantitative assay. Heart Lung Circ 21:12 (2012), 787–793.
50. 50 Moretti, M., Buiatti, A., Merlo, M., et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol 112:9 (2013), 1493–1498.